Cosmos Health (COSM) Projected to Post Quarterly Earnings on Friday

Cosmos Health (NASDAQ:COSM) is expected to issue its results on Friday, November 13th. Analysts expect Cosmos Health to post earnings of ($0.04) per share and revenue of $17.34 million for the quarter.

Cosmos Health (NASDAQ:COSM) last posted its quarterly earnings results on Tuesday, August 18th. The company reported ($0.10) earnings per share for the quarter, hitting the consensus estimate of ($0.10). The company had revenue of $19.32 million during the quarter, compared to the consensus estimate of $18.99 million. Cosmos Health had a negative return on equity of 56.88% and a negative net margin of 33.08%. On average, analysts expect Cosmos Health to post ($0.15) EPS for the current fiscal year and $0.07 EPS for the next fiscal year.

Cosmos Health Stock Performance

Shares of COSM stock opened at $0.20 on Wednesday. The firm’s 50 day moving average is $0.31 and its 200 day moving average is $0.30. The stock has a market capitalization of $19.91 million, a P/E ratio of -0.31 and a beta of 4.73. Cosmos Health has a 12 month low of $0.16 and a 12 month high of $0.77. The company has a current ratio of 1.05, a quick ratio of 0.92 and a debt-to-equity ratio of 0.15.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of Cosmos Health in a report on Wednesday, October 28th. Noble Financial initiated coverage on Cosmos Health in a report on Monday, October 26th. They set an “outperform” rating on the stock. One analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Hold”.

About Cosmos Health

Cosmos Health Inc. is a healthcare group that develops, manufactures and distributes pharmaceutical, nutraceutical and healthcare products. Its portfolio includes branded dietary supplements, vitamins and wellness products, as well as pharmaceutical products and medical devices distributed through retail, wholesale and online channels. The company markets its nutraceutical products under the Sky Premium Life brand, which offers supplements and other health and wellness products. Cosmos Health also has manufacturing and product-development activities through Cana Laboratories, a Greece-based pharmaceutical manufacturer that produces pharmaceutical and healthcare products for its own portfolio and third parties.